Discovering Novel Antibody-Based Diagnostics and Therapeutics To Address Unmet Medical Needs
ModiQuest founders developed the first diagnostics test for rheumatoid arthritis, marketed worldwide and included in the American College of Rheumatology (ACR) diagnostics criteria.
Read more >>ModiQuest's pipeline of preclinical candidates includes monoclonal and recombinant antibody therapeutics for prevention and treatment of established rheumatoid arthritis.
Read more >>Experts in monoclonal and recombinant antibody generation for autoimmune and oncology, with high throughput hybridoma and phage display technology.
Read more >>